Multi-Center Analysis of the Effect of Disease Subtype and Minimal Residual Disease on Allogeneic Stem Cell Transplantation Outcomes in T-Cell Acute Lymphoblastic Leukemia (T-ALL)

MLA

Sa Wang, et al. “Multi-Center Analysis of the Effect of Disease Subtype and Minimal Residual Disease on Allogeneic Stem Cell Transplantation Outcomes in T-Cell Acute Lymphoblastic Leukemia (T-ALL).” Blood, vol. 126, Dec. 2015, p. 4408. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........1acf5cc7dc6221f59cfe4bcbfddb50f2&authtype=sso&custid=ns315887.

APA

Sa Wang, Jonathan E. Brammer, Elizabeth J. Shpall, Rima M. Saliba, Celina Ledesma, Liang Piu Koh, Gabriela Rondon, Michelle Poon, Farhad Ravandi, Partow Kebriaei, Richard E. Champlin, William Dibb, Uday R. Popat, Guang Fan, Chitra Hosing, Hagop M. Kantarjian, Richard T. Maziarz, Cynthia K Saliba, & Jeffrey L. Jorgensen. (2015). Multi-Center Analysis of the Effect of Disease Subtype and Minimal Residual Disease on Allogeneic Stem Cell Transplantation Outcomes in T-Cell Acute Lymphoblastic Leukemia (T-ALL). Blood, 126, 4408.

Chicago

Sa Wang, Jonathan E. Brammer, Elizabeth J. Shpall, Rima M. Saliba, Celina Ledesma, Liang Piu Koh, Gabriela Rondon, et al. 2015. “Multi-Center Analysis of the Effect of Disease Subtype and Minimal Residual Disease on Allogeneic Stem Cell Transplantation Outcomes in T-Cell Acute Lymphoblastic Leukemia (T-ALL).” Blood 126 (December): 4408. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........1acf5cc7dc6221f59cfe4bcbfddb50f2&authtype=sso&custid=ns315887.